Delila Gasi Tandefelt

Author

Institute of Cancer Research ORCID

Also Known As

D. Gasi Tandefelt, Delila Gasi, Delila Gasi Tandefelt

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Royal Marsden NHS Foundation Trust University of Trento Istituti di Ricovero e Cura a Carattere Scientifico

About

Delila Gasi Tandefelt is an author at Institute of Cancer Research specializing in medicine, systems biology, and functional genomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	63
2	Pathology	1	1	34
3	Cancer Genetics	1	1	34
4	Functional Genomics	1	1	29
5	Gene Expression	1	1	29

Delila Gasi Tandefelt

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Plasma <i>AR</i> and abiraterone-resistant prostate cancer Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Science Translational Medicine	2015	431
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani, Annals of Oncology	2017	263
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration Jean‐Sébastien Frenel, Suzanne Carreira, Jane Goodall, Clinical Cancer Research	2015	183
Overexpression of Prostate-Specific <i>TMPRSS2(exon 0)-ERG</i> Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer Karin G. Hermans, Joost L. Boormans, Delila Gasi Tandefelt, Clinical Cancer Research	2009	89
A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate Cancers Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, European Urology UrologyGenitourinary CancerMedicineErg-positive Prostate CancersPathology	2013	34
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, British Journal of Cancer	2020	33
Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation Delila Gasi Tandefelt, Hetty A. van der Korput, Hannie Douben, PLoS ONE Full-length Etv1 TranscriptsFusion TranscriptTumor HeterogeneityGeneticsGene Translocation	2011	29
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data Dimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, BMC Medical Genomics	2019	10

Page 1